United Orthopedic (4129) - Cash Flow Conversion Efficiency
Based on the latest financial reports, United Orthopedic (4129) has a cash flow conversion efficiency ratio of 0.053x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$223.65 Million ≈ $7.05 Million USD) by net assets (NT$4.20 Billion ≈ $132.46 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See United Orthopedic balance sheet independence to measure how much of total assets are equity-financed.
United Orthopedic - Cash Flow Conversion Efficiency Trend (2015–2025)
This chart illustrates how United Orthopedic's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check how high is United Orthopedic's earnings quality to evaluate the quality of earnings relative to operating cash generation.
United Orthopedic Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of United Orthopedic ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Transportadora de Gas del Norte SA Class C
BA:TGNO4
|
0.076x |
|
Krakatau Steel Persero Tbk
JK:KRAS
|
-0.195x |
|
Fine Semitech Corp
KQ:036810
|
-0.021x |
|
DYNAM JAPAN HOLDINGS Co. Ltd
F:2DJ
|
0.102x |
|
Jiangxi Hengda Hi-Tech Co Ltd
SHE:002591
|
-0.032x |
|
Smart Share Global Ltd ADR
NASDAQ:EM
|
0.043x |
|
Shandong Swan Cotton
SHG:603029
|
0.071x |
|
Praetorian Acquisition Corp. Class A Ordinary Shares
NASDAQ:PTOR
|
N/A |
Annual Cash Flow Conversion Efficiency for United Orthopedic (2015–2025)
The table below shows the annual cash flow conversion efficiency of United Orthopedic from 2015 to 2025. For the full company profile with market capitalisation and key ratios, see how much is United Orthopedic worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | NT$4.20 Billion ≈ $132.46 Million |
NT$1.03 Billion ≈ $32.32 Million |
0.244x | +34.36% |
| 2024-12-31 | NT$3.95 Billion ≈ $124.45 Million |
NT$717.29 Million ≈ $22.60 Million |
0.182x | +63.81% |
| 2023-12-31 | NT$3.59 Billion ≈ $113.23 Million |
NT$398.43 Million ≈ $12.55 Million |
0.111x | +0.51% |
| 2022-12-31 | NT$3.09 Billion ≈ $97.35 Million |
NT$340.79 Million ≈ $10.74 Million |
0.110x | -7.03% |
| 2021-12-31 | NT$2.82 Billion ≈ $88.87 Million |
NT$334.64 Million ≈ $10.54 Million |
0.119x | -27.95% |
| 2020-12-31 | NT$2.93 Billion ≈ $92.15 Million |
NT$481.65 Million ≈ $15.17 Million |
0.165x | -1.89% |
| 2019-12-31 | NT$2.93 Billion ≈ $92.43 Million |
NT$492.45 Million ≈ $15.51 Million |
0.168x | +2943.61% |
| 2018-12-31 | NT$2.25 Billion ≈ $70.90 Million |
NT$12.41 Million ≈ $390.98K |
0.006x | +321.95% |
| 2017-12-31 | NT$2.22 Billion ≈ $69.88 Million |
NT$2.90 Million ≈ $91.33K |
0.001x | -98.68% |
| 2016-12-31 | NT$1.80 Billion ≈ $56.76 Million |
NT$179.03 Million ≈ $5.64 Million |
0.099x | -30.29% |
| 2015-12-31 | NT$1.77 Billion ≈ $55.86 Million |
NT$252.75 Million ≈ $7.96 Million |
0.143x | -- |
About United Orthopedic
United Orthopedic Corporation engages in the research, development, manufacture, and sale of orthopedic implants and surgical equipment in Taiwan, Asia, America, Europe, Africa, and Oceania. The company offers artificial hip joints, partial hip joints, joints for large trochanteric fractures, Moore hip prostheses, and customized artificial hip joints for individual tumor patients; artificial knee… Read more